An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To provide oral ganciclovir to patients who require maintenance for control of
cytomegalovirus (CMV) retinitis, but who lack patent permanent central venous access for
long-term administration of intravenous drugs.